AIM ImmunoTech Inc. (AIM) stock
AIMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.15+0.00 (+0.13%)
Close on Nov 12, 2026Market cap $4.52MP/E –Yield –
AIM ImmunoTech cash
Cash and short-term investments held at the end of each period.
AIM ImmunoTech's cash was $6.95M at Sep 30, 2026. For fiscal 2025 it was $3.05M, down 23.4% from the year before. Over ten years it grew 3.7% a year on average. The highest annual figure on record is $58.07M in fiscal 2009.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.05M | -23.4% |
| FY2024 | Dec 31, 2024 | $3.98M | -69.6% |
| FY2023 | Dec 31, 2023 | $13.07M | -61.8% |
| FY2022 | Dec 31, 2022 | $34.19M | -29.2% |
| FY2021 | Dec 31, 2021 | $48.27M | -11.2% |
| FY2020 | Dec 31, 2020 | $54.38M | +519.5% |
| FY2019 | Dec 31, 2019 | $8.78M | +2835.8% |
| FY2018 | Dec 31, 2018 | $299.00K | -78.8% |
| FY2017 | Dec 31, 2017 | $1.41M | -41.4% |
| FY2016 | Dec 31, 2016 | $2.41M | +13.9% |
| FY2015 | Dec 31, 2015 | $2.12M | -1.9% |
| FY2014 | Dec 31, 2014 | $2.16M | +168.5% |
| FY2013 | Dec 31, 2013 | $803.00K | -63.7% |
| FY2012 | Dec 31, 2012 | $2.21M | -28.7% |
| FY2011 | Dec 31, 2011 | $3.10M | +6.3% |
| FY2010 | Dec 31, 2010 | $2.92M | -95.0% |
| FY2009 | Dec 31, 2009 | $58.07M | +849.0% |
| FY2008 | Dec 31, 2008 | $6.12M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $6.95M | +188.4% |
| Q2 FY2026 | Jun 30, 2026 | $9.96M | +1093.3% |
| Q1 FY2026 | Mar 31, 2026 | $5.88M | +161.6% |
| Q4 FY2025 | Dec 31, 2025 | $3.05M | -23.4% |
| Q3 FY2025 | Sep 30, 2025 | $2.41M | -66.6% |
| Q2 FY2025 | Jun 30, 2025 | $835.00K | -91.7% |
| Q1 FY2025 | Mar 31, 2025 | $2.25M | -79.5% |
| Q4 FY2024 | Dec 31, 2024 | $3.98M | -69.6% |
| Q3 FY2024 | Sep 30, 2024 | $7.20M | -67.9% |
| Q2 FY2024 | Jun 30, 2024 | $10.06M | -64.6% |
| Q1 FY2024 | Mar 31, 2024 | $10.94M | -68.0% |
| Q4 FY2023 | Dec 31, 2023 | $13.07M | -64.4% |
| Q3 FY2023 | Sep 30, 2023 | $22.43M | -46.3% |
| Q2 FY2023 | Jun 30, 2023 | $28.40M | -36.2% |
| Q4 FY2022 | Dec 31, 2022 | $34.19M | -29.2% |
| Q3 FY2022 | Sep 30, 2022 | $36.75M | -31.5% |
| Q2 FY2022 | Jun 30, 2022 | $41.77M | -27.1% |
| Q1 FY2022 | Mar 31, 2022 | $44.54M | -30.0% |
| Q4 FY2021 | Dec 31, 2021 | $48.27M | -11.2% |
| Q3 FY2021 | Sep 30, 2021 | $53.66M | -1.5% |
| Q2 FY2021 | Jun 30, 2021 | $57.28M | +42.1% |
| Q1 FY2021 | Mar 31, 2021 | $63.60M | +104.6% |
| Q4 FY2020 | Dec 31, 2020 | $54.38M | +519.5% |
| Q3 FY2020 | Sep 30, 2020 | $54.48M | +466.5% |
| Q2 FY2020 | Jun 30, 2020 | $40.31M | +4103.2% |
| Q1 FY2020 | Mar 31, 2020 | $31.08M | +1198.2% |
| Q4 FY2019 | Dec 31, 2019 | $8.78M | +2835.8% |
| Q3 FY2019 | Sep 30, 2019 | $9.62M | +137.1% |
| Q2 FY2019 | Jun 30, 2019 | $959.00K | -73.1% |
| Q1 FY2019 | Mar 31, 2019 | $2.39M | -39.5% |
| Q4 FY2018 | Dec 31, 2018 | $299.00K | -78.8% |
| Q3 FY2018 | Sep 30, 2018 | $4.06M | +706.2% |
| Q2 FY2018 | Jun 30, 2018 | $3.57M | +192.0% |
| Q1 FY2018 | Mar 31, 2018 | $3.96M | +409.9% |
| Q4 FY2017 | Dec 31, 2017 | $1.41M | -41.4% |
| Q3 FY2017 | Sep 30, 2017 | $503.00K | -88.8% |
| Q2 FY2017 | Jun 30, 2017 | $1.22M | – |
| Q1 FY2017 | Mar 31, 2017 | $776.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $2.41M | – |
| Q3 FY2016 | Sep 30, 2016 | $4.47M | – |
See a number that looks wrong?